adjuvant chemo- and immuno-therapy with dacarbazine ( 1st to 5th day 250 mg/m2 daily ) and bcg ( 6th day 0.01 ml intracutaneously ) was administered to a 50-year-old male patient in a three-week cycle after surgical removal of a superficially spreading malignant melanoma .
C0010927
dacarbazine
C0025202
malignant melanoma